Optimal ratio of remazolam besylate to esketamine in the intravenous anesthesia patients undergoing endoscopic retrograde cholangiopancreatography

doi:10.3969/j.issn.1672-3384.2022.12.015

WANG Yan, HU Zhi-yuan, MIAO Zhen-hua, LI Jun-qing, LIU Hong-xia, WU Meng-hao, LI Pei, GUO Quang-zhou, YAN Li-hui, LIANG Dong-hong

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (12) : 76-81.

PDF(628 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (12) : 76-81. DOI: 10.3969/j.issn.1672-3384.2022.12.015

Original Article

Optimal ratio of remazolam besylate to esketamine in the intravenous anesthesia patients undergoing endoscopic retrograde cholangiopancreatography

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(12): 76-81 https://doi.org/10.3969/j.issn.1672-3384.2022.12.015

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(628 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-08-31	2022-12-29
Issue Date
2022-12-29

Please choose a citation manager

Content to export